Information Provided By: 
Fly News Breaks for May 30, 2018
WCG
May 30, 2018 | 06:07 EDT
"The Meridian deal is unexpected, but we like it," Piper Jaffray analyst Sarah James tells investors in a research note on WellCare. The analyst keeps an Overweight rating on the shares with a $235 price target. The $2.5B price seems like a good deal, valuing Medicaid members at $3,000 and Medicare Advantage $12,000 based on recent comps, the analyst adds. James believes the deal could bring upside to earnings for WellCare.
News For WCG From the Last 2 Days
There are no results for your query WCG
